Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Celeste Gobbi
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
University of Zurich,
University Hospital Zurich
ORCID:
0009-0007-1772-5912
Observed ORCID:
0009-0007-1772-5912
OpenAlex ID:
A5129711012
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
·
Molecular Cancer Therapeutics
·
1
PDF
Supplementary Table S2 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Table S1 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S4 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S1 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S5 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Data from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S2 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S3 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S5 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 4 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S3 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 5 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Table S1 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S6 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S4 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 3 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S1 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Data from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Table S2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S7 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 1 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
·
Cancer Research Communications
Show more works
View as search
Works count:
25
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type